Malignancy risk in patient with neurofibromatosis and autosomal dominant polycystic kidney disease

Croatian Medical Journal

Volumn 44, Issue 4, 2003, Pages 485-488

  Flego, Veljko ^a   Badovinac, Andelka Radojčić ^b   Pleše, Vika ^c   Kapović, Miljenko ^b   Beg Zec, Zlata ^a   Zaputović, Luka ^a  

^a KBC RIJEKA   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c Delnice Health Center   (Croatia)

Author keywords

Adenocarcinoma; Chromosomes, human, pair 9; Inversion (genetics); Lung neoplasms; Neurofibromatosis; Polycystic kidney diseases; Pseudoarthrosis; Tibia

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CASE REPORT; CHROMOSOME 9; CHROMOSOME INVERSION 9; CLINICAL FEATURE; COUGHING; CYTOGENETICS; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; FAMILY HISTORY; FEVER; GENE INTERACTION; HUMAN; HUMAN TISSUE; KIDNEY POLYCYSTIC DISEASE; LUNG ADENOCARCINOMA; MALE; NEUROFIBROMATOSIS; PLEURA EFFUSION; PSEUDARTHROSIS; THORAX PAIN; TIBIA; TREATMENT OUTCOME; VERTICAL TRANSMISSION; WEIGHT REDUCTION;

ADENOCARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 9; FATAL OUTCOME; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROFIBROMATOSES; PALLIATIVE CARE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RADIOTHERAPY; RISK ASSESSMENT;

EID: 0042839406     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Viskochil D, White R, Cawthon R. The neurofibromatosis type 1 gene. Annu Rev Neurosci 1993;16: 183-205.
2. McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R, et al. A clinical study of type 1 neurofibromatosis in northwest England. J Med Genet 1999;36:197-203.
3. Fuyuno G, Kobayashi R, Iga R, Horio H, Nomori H, Kodera K, et al. A case of Von Recklinghausen's disease associated with a hemothorax due to a rapidly growing malignant schwannoma [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1995;33:682-5.
4. Fukuoka K, Katada H, Kohnoike Y, Narita N, Ioka S. A case of Von Recklinghausen's disease associated with large cell carcinoma of the lung [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1993;31:88-93.
5. Gomes H, Lebre R, Fonseca J, Borralho P, Duarte R. Adenocarcinoma of the Vater's ampulla associated with Von Recklinghausen's neurofibromatosis [in Spanish]. Acta Med Port 1997;10:832-6.
6. Nakamura M, Tangoku A, Kusanagi H, Oka M, Suzuki T. Breast cancer associated with Recklinghausen's disease: report of a case. Nippon Geka Hokan 1998;67: 3-9.
7. Li C, Cheng Y, Gutmann DA, Mangoura D. Differential localization of the neurofibromatosis 1 (NF 1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. Brain Res Dev Brain Res 2001;130: 231-48.
8. Yla-Outinen H, Koivunen J, Nissinen M, Bjorkstrand AS, Paloniemi M, Korkiamaki T, et al. NF1 tumor suppressor mRNA is targeted to the cell-cell contact zone in Ca (2+)-induced keratinocyte differentiation. Lab Invest 2002;82:353-61.
9. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, et al. Somatic mutations in the neurofibromatosis 1 gene in human tumours. Cell 1992;69:275-81.
10. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996;33:2-17.
11. Hsueh YP, Roberts AM, Volta M, Sheng M, Roberts RG. Bipartite interaction between neurofibromatosis type 1 protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans. J Neurosci 2001;21: 3764-70.
12. Coto E, Sanz de Castro S, Aguado S, Alvarez J, Arias M, Menéndez MJ, et al. DNA microsatellite analysis of families with autosomal dominant polycystic kidney disease types 1 and 2: evaluation of clinical heterogeneity between both forms of the disease. J Med Genet 1995;32:442-5.
13. Constantinou-Deltas CD, Papageorgiou E, Boteva K, Christodoulou K, Breuning MH, Peter DJ, et al. Genetic heterogeneity in adult dominant polycystic kidney disease in Cypriot families. Hum Genet 1995;95:416-23.
14. van der Linden E, Bartelink AK, Ike BW, van Leeuwaarden B. Polycystic kidney disease and infertility. Fertil Steril 1995;64:202-3.
15. Orhan I, Onur R, Ergin E, Koksal IT, Kadioglu A. Infertility treatment in autosomal dominant polycystic kidney disease (ADPKD) - a case report. Andrologia 2000;32: 91-3.
16. Jeffery S, Saggar-Malik AK, Morgan S, Eastwood JB, Patton M. Genetic analysis of 20 families with autosomal dominant adult polycystic kidney disease from South West Thames Region. Clin Genet 1995;47:290-4.
17. Moorhead PS, Nowell PC, Mellman WJ, Battips DM, Hugerford DA. Chromosome preparation of leukocyte cultured from human peripheral blood. Exper Cell Res 1960;20:613-6.
18. Lothe RA, Saeter G, Danielsen HE, Stenwig AE, Hoyheim B, O'Connell P, et al. Genetic alteration in a malignant schwannoma from a patient with neurofibromatosis (NF1). Pathol Res Pract 1993;189:465-74.
19. Shimizu Y, Tsuchiya S, Watanabe S, Saitoh R. von Recklinghausen's disease with lung cancer derived from the wall of emphysematous bullae. Intern Med 1994;33:167-71.
20. Itoi K, Yanagihara K, Okubo K, Kuwabara M. A case of lung cancer in a patient with von Recklinghausen's disease [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1992;30:317-21.
21. Shimizu E, Shinohara T, Mori N, Yokota J, Tani K, Izumi K, et al. Loss of heterozygosity on chromosome arm 17p in small cell lung carcinomas, but not in neurofibromas, in a patient with von Recklinghausen neurofibromatosis. Cancer 1993;71:725-8.
22. Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med 1981;305:1617-27.
23. Boero S, Catagni M, Donzelli O, Facchini R, Frediani PV. Congenital pseudoarthrosis of the tibia associated with neurofibromatosis-1: treatment with Ilizarov's device. J Pediatr Orthop 1997;17:675-84.
24. Ramesh KH, Verma RS. Breakpoints in alpha, beta, and satellite III DNA sequences of chromosome 9 result in a variety of pericentric inversions. J Med Genet 1996;33: 395-8.
25. Macera MJ, Verma RS, Conte RA, Bialer MG, Klein VR. Mechanisms of the origin of an extra G-positive band within the secondary constriction region of human chromosome 9. Cytogenet Cell Genet 1995;69:235-9.
26. Kishimoto Y, Sugio K, Hung JY, Virmani AK, McIntire DD, Minna JD, et al. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying nonsmall-cell lung cancers. J Natl Cancer Inst 1995;87: 1224-9.
27. Kohno H, Hiroshima K, Toyozaki T, Fujisawa T, Ohwada H. p53 mutation and allelic loss of chromosome 3p,9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma. Cancer 1999;85:341-7.